Diabetic gastroparesis: What to do when gastric emptying is delayed

D. W. Clark, Thomas Nowak

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Diagnostic evidence or symptoms of gastroparesis develop in about 20% to 30% of patients with long-standing diabetes. Diabetic gastroparesis is likely caused by autonomic neuropathy involving the nerves that regulate gastric motor function. The following are necessary for diagnosis: thorough history taking and physical examination to eliminate factors that might further delay gastric emptying; esophagogastroduodenoscopy or barium contrast studies to exclude structural abnormalities; and a radionuclide gastric emptying study. The three main agents available for therapy in the United States are metoclopramide (Maxolon, Octamide, Reglan), erythromycin, and cisapride (Propulsid). All have been shown to offer benefit in improving gastric emptying and symptoms, although use of metoclopramide is limited by a significant incidence of side effects. Surgical intervention should be avoided if possible.

Original languageEnglish (US)
Pages (from-to)195-198+201
JournalPostgraduate Medicine
Volume95
Issue number5
StatePublished - 1994
Externally publishedYes

Fingerprint

Gastroparesis
Metoclopramide
Gastric Emptying
Cisapride
Digestive System Endoscopy
Erythromycin
Barium
Radioisotopes
Physical Examination
Stomach
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Diabetic gastroparesis : What to do when gastric emptying is delayed. / Clark, D. W.; Nowak, Thomas.

In: Postgraduate Medicine, Vol. 95, No. 5, 1994, p. 195-198+201.

Research output: Contribution to journalArticle

@article{86fa4f257e7445fca783bc52a9b3219e,
title = "Diabetic gastroparesis: What to do when gastric emptying is delayed",
abstract = "Diagnostic evidence or symptoms of gastroparesis develop in about 20{\%} to 30{\%} of patients with long-standing diabetes. Diabetic gastroparesis is likely caused by autonomic neuropathy involving the nerves that regulate gastric motor function. The following are necessary for diagnosis: thorough history taking and physical examination to eliminate factors that might further delay gastric emptying; esophagogastroduodenoscopy or barium contrast studies to exclude structural abnormalities; and a radionuclide gastric emptying study. The three main agents available for therapy in the United States are metoclopramide (Maxolon, Octamide, Reglan), erythromycin, and cisapride (Propulsid). All have been shown to offer benefit in improving gastric emptying and symptoms, although use of metoclopramide is limited by a significant incidence of side effects. Surgical intervention should be avoided if possible.",
author = "Clark, {D. W.} and Thomas Nowak",
year = "1994",
language = "English (US)",
volume = "95",
pages = "195--198+201",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "5",

}

TY - JOUR

T1 - Diabetic gastroparesis

T2 - What to do when gastric emptying is delayed

AU - Clark, D. W.

AU - Nowak, Thomas

PY - 1994

Y1 - 1994

N2 - Diagnostic evidence or symptoms of gastroparesis develop in about 20% to 30% of patients with long-standing diabetes. Diabetic gastroparesis is likely caused by autonomic neuropathy involving the nerves that regulate gastric motor function. The following are necessary for diagnosis: thorough history taking and physical examination to eliminate factors that might further delay gastric emptying; esophagogastroduodenoscopy or barium contrast studies to exclude structural abnormalities; and a radionuclide gastric emptying study. The three main agents available for therapy in the United States are metoclopramide (Maxolon, Octamide, Reglan), erythromycin, and cisapride (Propulsid). All have been shown to offer benefit in improving gastric emptying and symptoms, although use of metoclopramide is limited by a significant incidence of side effects. Surgical intervention should be avoided if possible.

AB - Diagnostic evidence or symptoms of gastroparesis develop in about 20% to 30% of patients with long-standing diabetes. Diabetic gastroparesis is likely caused by autonomic neuropathy involving the nerves that regulate gastric motor function. The following are necessary for diagnosis: thorough history taking and physical examination to eliminate factors that might further delay gastric emptying; esophagogastroduodenoscopy or barium contrast studies to exclude structural abnormalities; and a radionuclide gastric emptying study. The three main agents available for therapy in the United States are metoclopramide (Maxolon, Octamide, Reglan), erythromycin, and cisapride (Propulsid). All have been shown to offer benefit in improving gastric emptying and symptoms, although use of metoclopramide is limited by a significant incidence of side effects. Surgical intervention should be avoided if possible.

UR - http://www.scopus.com/inward/record.url?scp=0028316695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028316695&partnerID=8YFLogxK

M3 - Article

C2 - 8153043

AN - SCOPUS:0028316695

VL - 95

SP - 195-198+201

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 5

ER -